ArticleCase reports in oncology

Successful Treatment of Nivolumab-Resistant Multiple In-Transit Melanomas with Ipilimumab and Topical Imiquimod.

Taku Fujimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.